WHO deems two Ebola vaccines ‘acceptably safe’

Two vaccines for treating the Ebola Virus Disease (EVD), which have already undergone the first phase of trials, were deemed to be acceptably safe by the World Health Organization (WHO) Friday

The two potential vaccines that have been undergoing phase one safety tests on humans are ChAd3, made by Britain’s GlaxoSmithKline, and VSV-EBOV, manufactured by the Public Health Agency of Canada and licensed by the US firm NewLink Genetics.

As of Friday, the total number of cases attributed to EVD in West Africa reached 20,972, of which 8,259 people have died.

CLICK HERE TO READ IN FULL HERE